Overview

MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the toxicity and activity of weekly administration of carboplatin and paclitaxel as first-line chemotherapy for elderly patients with ovarian cancer stage IC-IV.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute, Naples
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel